Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#532 most reported symptom for this vaccine
Blood alkaline phosphatase increased has been reported 25 times in association with Pneumococcal (Prevnar13) vaccination in VAERS. This represents 0.1% of all 33,058 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 21 involved hospitalization (84.0%).
Blood alkaline phosphatase increased is the #532 most frequently reported symptom for Pneumococcal (Prevnar13) out of 1920 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 25 reports of Blood alkaline phosphatase increased after Pneumococcal (Prevnar13) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.